Portal for

    You are here

    Medical Biotechnology - 24-25 MAY 2018, GHENT, BELGIUM

    Medical Biotechnology

    24-25 MAY 2018, GHENT, BELGIUM 


    "Medical Biotechnology is in an era of rapid transformation because of new disruptive technologies for early diagnosis and more effective therapeutic intervention, even in established chronic diseases,"  said Nico Callewaert of the VIB-UGent Center for Medical Biotechnology and organizing committee member of this conference. "VIB organizes this focus meeting to provide cutting edge insight delivered by top scientists from academia and industry."

    During four plenary sessions the following topics will be covered:

    • biopharmaceutical technology
    • targeted delivery
    • diagnostics & biomarkers
    • vaccines

    In addition to the scientific sessions there will be ample opportunities to network during the breaks, posters sessions, reception and conference dinner.

    Especially for junior researchers a ‘Meet the Expert' session with Dr. Annemieke Geluk will be organized on the 24th of May. During an informal round table discussion PhD students and postdocs will have the exclusive opportunity to ask any question/advise related to their research and careers. If you are interested in joining the session, then send an e-mail to conferences@vib.be. Seating is limited.

    Poster information:
    Format: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation


    • Early Bird: 15 April 2018
    • Late Registration: 10 May 2018
    • Abstract deadline: 26 March 2018

    Website link: https://vibconferences.be/event/medical-biotechnology


    UGent - Aula Universiteit Gent
    Voldersstraat 9
    9000 Gent

    Speakers including:

    • Carl June - Perelman School of Medicine, UPenn, US
    • Gary J. Nabel - Sanofi Global R&D, US
    • Michael Snyder - Center for Genomics and Personalized Medicine, Stanford University, US
    • John C. Bell - University of Ottawa, CA
    • Ashley – Birkett, PATH, US
    • Mustafa Diken - University Medical Center of the Johannes Gutenberg University Mainz, DE
    • Heidi Rommelaere- Ablynx, BE
    • Annemieke Geluk - LUMC Leiden, NL
    • David Gilham -Celyad, UK
    • An Hendrix -Ghent University, BE
    • Nathalie Heuzé Vourc’h - INSERM UMR 1100, Tours , FR
    • Florian Krammer - Mount Sinai School of Medicine, US
    • Mike Makrigiorgos - Dana Farber Cancer Institute, Harvard Medical School, US
    • Rogier Sanders - AMC, UvA, NL
    • Danica  Stanimirovic -National Research Council, CA
    • Jan Tavernier - VIB-UGent Center for Medical Biotechnology, BE
    • Ryan Watts - Denali Therapeutics, US